Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 12, 2023

BUY
$96.41 - $126.61 $16,389 - $21,523
170 New
170 $17,000
Q4 2021

Jan 11, 2022

SELL
$225.82 - $368.51 $1.25 Million - $2.04 Million
-5,537 Closed
0 $0
Q3 2021

Oct 07, 2021

BUY
$221.9 - $484.47 $1.23 Million - $2.68 Million
5,537 New
5,537 $2 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Rvw Wealth, LLC Portfolio

Follow Rvw Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rvw Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rvw Wealth, LLC with notifications on news.